PODOFILOX - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for podofilox and what is the scope of patent protection?

Podofilox is the generic ingredient in two branded drugs marketed by Allergan, Padagis Us, Teva Branded Pharm, and Bausch And Lomb Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for podofilox. Three suppliers are listed for this compound.

Summary for PODOFILOX

US Patents:	0
Tradenames:	2
Applicants:	4
NDAs:	5
Drug Master File Entries:	2
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	93
Clinical Trials:	1
Patent Applications:	6,781
Drug Prices:	Drug price trends for PODOFILOX
What excipients (inactive ingredients) are in PODOFILOX?	PODOFILOX excipients list
DailyMed Link:	PODOFILOX at DailyMed

See drug prices for PODOFILOX

Recent Clinical Trials for PODOFILOX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
bioRASI, LLC	Phase 3
Dermax SA	Phase 3
Hyloris Developments SA	Phase 3

See all PODOFILOX clinical trials

Pharmacology for PODOFILOX

Physiological Effect	Decreased Mitosis

US Patents and Regulatory Information for PODOFILOX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch And Lomb Inc	PODOFILOX	podofilox	SOLUTION;TOPICAL	090184-001	Jul 21, 2010		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Us	PODOFILOX	podofilox	GEL;TOPICAL	211871-001	Nov 22, 2023	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Branded Pharm	CONDYLOX	podofilox	SOLUTION;TOPICAL	019795-001	Dec 13, 1990	AT	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PODOFILOX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	CONDYLOX	podofilox	GEL;TOPICAL	020529-001	Mar 13, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	CONDYLOX	podofilox	GEL;TOPICAL	020529-001	Mar 13, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.